The Trump administration is developing a new drug control strategy that includes wastewater testing and artificial intelligence to monitor illegal drug use, according to a draft document obtained by CBS News.

The proposed strategy calls for real-time data collection on drug use through wastewater analysis and the deployment of AI systems to track emerging threats in the illegal drug market. The administration views these technological approaches as part of a broader effort to combat the ongoing drug crisis.

Meanwhile, concerns have emerged about funding for fentanyl test strips, which cost approximately $1 each and allow users to check drugs for dangerous contaminants including fentanyl and xylazine. Critics of potential funding cuts argue that the strips serve as an important harm reduction tool.

The timing of these developments highlights competing approaches to addressing drug abuse, with the new administration emphasizing surveillance and data collection while questions persist about support for existing prevention tools. Fentanyl test strips have been used by harm reduction programs to help prevent overdoses by alerting users to the presence of the synthetic opioid in other substances.

The draft strategy represents part of the Trump administration's broader approach to drug policy, though specific implementation timelines and funding details have not been disclosed.